Asymmetric oxidation of vinyl- and ethynyl terthiophene ligands in triruthenium complexes

A series of ruthenium(II) complexes [{RuCl(CO)(PMe3)3(–CHvCH–)}nX], 1a–1c (1a: n = 3, X = 3,3’’- dimethyl-2,2’:3’,2’’-terthiophene; 1b: n = 2, X = 2,2’-bithiophene; 1c: n = 2, X = 2,3-bis(3-methylthiophen- 2-yl)benzothiophene) and [{Cp*(dppe)2Ru(–CuC–)}3X], 1d (X = 3,3’’-dimethyl-2,2’:3’,2’’- terthiophene), were prepared and characterized by 1H, 13C and 31P NMR. Their redox, spectroscopic and bonding properties were studied with a range of spectro-electrochemical methods in combination with density functional theory calculations. The first two anodic steps observed for 1a and 1d are largely localized on the lateral frameworks of the molecular triangle, the direct conjugation between them being precluded due to the photostable open form of the dithienyl ethene moiety. The third anodic step is then mainly localized on the centerpiece of the triangular structure, affecting both bithiophene laterals. The experimental IR and UV-vis-NIR spectroelectrochemical data and, largely, also DFT calculations account for this explanation, being further supported by direct comparison with the anodic behavior of reference diruthenium complexes 1b and 1c.

Dependence of the product on the P-P ligand in reactions of [RuCl(3)(NO)(P-P)] complexes (P-P = aromatic diphosphines) with 2-mercaptopyridine

This study presents the syntheses and characterization of 2-mercaptopyridine (pyS(-)) complexes containing ruthenium(II) with the following general formula [Ru(pyS)(2)(P-P)], P-P = (c-dppen) = cis-1,2-bis(diphenylphosphino)ethylene) (1); (dppe)=1,2-bis(diphenylphosphino)ethane (2); (dppp)=1,3-bis(diphenylphosphino)propane (3) and (dppb) = 1,4-bis(diphenylphosphino)butane (4). The complexes were synthesized from the mer- or fac-[RuCl(3)(NO)(P-P)] precursors in the presence of triethylamine in methanol solution with dependence of the product on the P-P ligand. The reaction of pyS- with a ruthenium complex containing a bulky aromatic diphosphine dppb disclosed a major product with a dangling coordinated dppbO-P, the [Ru(pyS)(2)(NO)(eta(1)-dppbO-P)]PF(6) (5). In addition, this work also presents and discusses the spectroscopic and electrochemical behavior of 1-5. and report the X-ray structures for I and S. (C) 2009 Elsevier Ltd. All rights reserved.

Spectroscopic Investigation on the Formation of a Dinuclear Me(2)SO-Ru(2)-Mercaptopyridine Bridged Complex: [Ru(2)Cl(3)(mu-pyS)(mu-dmso)(dmso)(4)]center dot 2H(2)O

A dinuclear ruthenium(II) complex double-bridged by an N-aromatic ligand 2-mercaptopyridine (2-pyridinethiol or 2-pyridyl mercaptan) and a methyl sulfoxide (dmso) have been characterized by X-ray crystallography. The reported compound with formula [Ru(2)Cl(3) (mu-pyS)(mu-dmso)(dmso)(4)] center dot 2H(2)O, [C(15)H(36)Cl(3)NO(7)S(6)Ru(2)] (P2/c, a = 13.8175(2) angstrom, b = 10.5608(2) angstrom, c = 21.3544 (3) angstrom, beta = 106.090(1)degrees, V = 2,994.05(8) angstrom(3), Z = 4) represents a seven-membered ring system with both rutheniums in an octahedral geometry. All the hydrogen bonds (C-H-Cl) and the van der Waals contacts give rise to three-dimensional network in the structure and add stability to the dinuclear compound. To our knowledge, this is the first time that the formation of a dinuclear ruthenium(II) complex double-bridged by an N-aromatic ligand 2-mercaptopyridine and dmso have been reported. The study also provided valuable insight into bioinorganic chemistry as continuing efforts are being made to develop metal-based cancer chemotherapeutics. A major feature of this paper is the resolution of a double bridged ruthenium structure which contributes to a better understanding of ruthenium reactivity.

On the synthesis and structures of the complexes [RuCl(L)(dppb)(N-N)]PF(6) (L = CO, py or 4-NH(2)py; dppb=1,4-bis(diphenylphosphino)butane; N-N=2,2 `-bipyridine or 1,10-phenanthroline) and [(dppb)(CO)Cl(2)-Ru-pz-RuCl(2)(CO)(dppb)] (pz = pyrazine)

The ""Ru(P-P)"" unit (P-P = diphosphine) is recognized to be an important core in catalytic species for hydrogenation of unsaturated organic substrates. Thus, in this study we synthesized six new complexes containing this core, including the binuclear complex [(dppb)(CO)Cl(2)Ru-pz-RuCl(2)(CO)(dPPb)] (pz = pyrazine) which can be used as a precursor for the synthesis of cationic carbonyl species of general formula [RuCl(CO)(dppb)(N-N)]PF(6) (N-N = diimine). Complexes with the formula (RuCl(py)(dppb)(N-N)]PF(6) were synthesized by exhaustive electrolysis of these carbonyl compounds or from the precursors [RuCl(2)(dppb)(N-N)]. The new complexes were characterized by microanalysis, conductivity measurements, IR and (31)P{(1)H)} NMR spectroscopy, cyclic voltammetry and X-ray crystallography. (C) 2010 Elsevier Ltd. All rights reserved.

Synthesis, characterization and cytotoxic activities of the [RuCl(2)(NO)(dppp)(L)]PF(6) complexes

The synthesis and characterization of ruthenium compounds of the type [RuCl(2)(NO)(dppp)(L)]PF(6) [dppp = 1,3-bis(diphenylphosphino)propane; L = pyridine, 4-methylpyridine, 4-phenylpyridine and dimethyl sulfoxide] are described. The complexes were characterized by elemental analysis, UV/Vis and infrared spectroscopy, cyclic voltammetry, and X-ray crystallography for the complexes with the pyridine and 4-methylpyridine ligands. In vitro evaluation of these nitrosyl complexes revealed cytotoxic activity from 7.1 to 19.0 mu M against the MDA-MB-231 breast tumor cells and showed that, in this case, they are more active than the reference metallodrug cisplatin. The 1,3-bis(diphenylphosphino)propane and the N-heterocyclic ligands alone failed to show cytotoxic activities at the concentrations tested (maximum concentration utilized = 200 mu M). (C) 2009 Elsevier Inc. All rights reserved.

Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy

Ruthenium compounds have been actively studied as metallodrugs for cancer therapy. Representatives of ruthenium-based antitumor drugs are the classes of ruthenium(III)-chlorido-(N-ligand)complexes, including the drugs namely NAMI-A and KP1019 in clinical trials, and ruthenium(II)-arene organometallics, with some compounds currently undergoing advanced preclinical testing. An alternative approach for tumor-inhibiting metallodrugs is the coordination of metal ions to organic pharmaceuticals. The combination of antitumor-active ruthenium ion with biologically-active pro-ligands in single compounds can result in the enhancement of activity, for example through synergistic effects. In the present article, some developments in the ruthenium-based antitumor drugs field are briefly highlighted and recent studies on mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy are described. Novel organic pharmaceuticals-containing diruthenium(II, III)complexes have shown promising antitumor activity for C6 rat glioma - a model for glioblastoma multiforme (GBA).

Bifunctional silica nanoparticles for the exploration of biofilms of Pseudomonas aeruginosa

Luminescent silica nanoparticles are frequently employed for biotechnology applications mainly because of their easy functionalization, photo-stability, and biocompatibility. Bifunctional silica nanoparticles (BSNPs) are described here as new efficient tools for investigating complex biological systems such as biofilms. Photoluminescence is brought about by the incorporation of a silylated ruthenium(II) complex. The surface properties of the silica particles were designed by reaction with amino-organosilanes, quaternary ammonium-organosilanes, carboxylate-organosilanes and hexamethyldisilazane. BSNPs were characterized extensively by DRIFT, 13C and 29Si solid state NMR, XPS, and photoluminescence. Zeta potential and contact angle measurements exhibited various surface properties (hydrophilic/hydrophobic balance and electric charge) according to the functional groups. Confocal laser scanning microscopy (CLSM) measurements showed that the spatial distribution of these nanoparticles inside a biofilm of Pseudomonas aeruginosa PAO1 depends more on their hydrophilic/hydrophobic characteristics than on their size. CLSM observations using two nanosized particles (25 and 68 nm) suggest that narrow diffusion paths exist through the extracellular polymeric substances matrix. © 2013 Copyright Taylor and Francis Group, LLC.

Complexos contendo o ligante 2 - Mercaptopiridina derivados da série '[RUCL IND. 3(NO)(P-P)]'

Pós-graduação em Química - IQ

Aplicação do '[RuCl IND. 3(DPPB)H IND.2 O] na obtenção do complexos mono e binucleares

Pós-graduação em Química - IQ

Processos de preparação de complexos fosfínicos de rutênio contendo íon picolinato e/ou diiminas e/ou bifosfinas em sua estrutura, complexos fosfínicos de Rutênio obtidos pelos referidos processos e seus usos.

The invention relates to the synthesis and characterisation of ruthenium(II) phosphine complexes containing picolinate and/or diimine and/or biphosphine ions and having an outstanding pharmacological activity for inhibiting the growth of tuberculosis mycobacteria. These complexes can first be used in the chemical industry, and in the medium and long term, in the pharmaceutical industry. The invention also describes how the activity against tuberculosis bacillus was determined, and how the toxicity of the complexes against macrophage cells within which the tuberculosis bacillus grows was assessed.

Synthesis and characterization of [Ru(eta(6)-C10H14)(dppf)X][PF6] (X = Cl, Br, I, SnF3) compounds: The X-ray structure of [Ru(eta(6)-C10H14)(dppf)Cl][SnCl3]center dot 0.45CH(2)Cl(2)

The arene-ruthenium complex [Ru(eta(6)-C10H14)(dppf)Cl]PF6 (1) was used as a precursor for the syntheses of the [Ru(eta(6)-C10H14)(dppf)Br]PF6 (2), [Ru(eta(6)-C10H14)(dppf)I]PF6 (3). [Ru(eta(6)-C10H14)(dppf)SnF3]PF6 (4) and [Ru(eta(6)-C10H14)(dppf)Cl][SnCl3]center dot 0.45CH(2)Cl(2) (5) complexes by its reactions with KBr, Kl, SnF2 and SnCl2. respectively. All of the compounds were characterized by NMR, IR, Fe-57 and Sn-119-Mossbauer spectroscopy, and cyclic voltammetry. The single-crystal X-ray structure analysis of the [Ru(eta(6)-C10H14)(dppf)Cl] [SnCl3]center dot 0.45CH(2)Cl(2) complex revealed the expected piano-stool geometry. Cyclic voltammograms of the complexes showed only one quasi-reversible electrochemical process, involving the oxidation of Fe(II) and Ru(II) at the same potential, which was confirmed by exhaustive electrolysis experiments. Fe-57-Mossbauer parameters obtained for the complexes (1-5) were fitted with one doublet corresponding to a site of one iron(II). The Sn-119-Mossbauer parameters of the complex (4) indicate that tin is tetra covalent. (c) 2012 Elsevier Ltd. All rights reserved.

Oberflächenuntersuchungen von Metalla-Tetraazaporphyrinen

Ziel dieser Arbeit war es, ein System zu entwickeln, in dem ein durch Licht induzierter Elektronentransfer stattfinden kann. Dazu wurden ein Kupfer(II)- und ein Zink(II)Tetraazaporphyrin mit acht 4-tert-Butylphenyl-Substituenten synthetisiert (Cu4Dinit, Zn4Dinit). Die Energielücke von 1,85 eV zwischen HOMO und LUMO von Cu4Dinit in Lösung wurde mit Hilfe von Cyclovoltammetrie und UV/Vis-Messungen bestimmt. Somit ist sie größer als für Cu4Dinit Moleküle, die auf einer Oberfläche (Wolfram(100)) liegen und mit STM-, STS-Messungen untersucht wurden. Hier beträgt die Energielücke 1,35 eV, was durch eine Drehung der Phenylringe in die Ebene der Pyrrolringe des Makrozyklus und somit durch eine bessere Überlappung der Orbitale erklärt werden kann. Um die Wechselwirkung der Moleküle mit der Oberfläche zu untersuchen, wurde Cu4Dinit, wie oben beschrieben, auf Magnetit aufgedampft. Dadurch wurde ausschließlich die Wechselwirkung zwischen den Elektronenspins des Kupfer(II)-ions und den Elektronenspins des Eisens im Magnetit betrachtet. Durch Messungen der Röntgenabsorption und des XMCD-Effektes konnten das Spinmoment, Bahnmoment und das Gesamtmoment des Kupfers berechnet und eine anisotrope Kopplung des Elektronenspins des Kupferions zum Magnetit, in Abhängigkeit der Magnetisierungsrichtung des Magnetits, festgestellt werden. Wenn der Magnetit senkrecht zur Oberfläche (out-of-plane) magnetisiert ist, ist die Kopplung ferromagnetisch, während bei einer Magnetisierungsrichtung parallel zur Ebene (in-plane) des Magnetits der Elektronenspin des Kupfers antiferromagnetisch mit dem des Eisens koppelt. Dadurch muss der Hamiltonian, der die Wechselwirkung zwischen zwei Spins beschreibt, bei einer anisotropen Kopplung um einen ansiotropen Term ergänzt werden. Das Ergebnis, dass der Elektronenspin des Kupferions durch die Richtung der Magnetisierung des Magnetits beeinflusst werden kann, eröffnet neue Wege, um die Spinkonfiguration von auf der Oberfläche liegenden Molekülen mit ungepaarten Elektronen, wie die zentralen Metallionen der Makrozyklen aber auch die Elektronenspins anderer metallorganischer Komplexe oder molekulare Magnete, durch ein externes Magnetfeld zu beeinflussen. rnDurch die stöchiometrische Templatreaktion von Pyrazino[2,3-f][1,10]-phenanthrolin-2,3-di-carbonitril (Dicnq), Bis(4-tert-Butylphenyl)-fumarodinitril (Dinit) und Kupfer(II)-acetat wurde eine Koordinationsmöglichkeit für ein Ruthenium(II)-ion in einem Tetraazaporphyrin hergestellt und so die Makrozyklen Cu3Dinit1Dicnq und Zn3Dinit1Dicnq synthetisiert, mit Rutheniumionen versetzt und ebenfalls mit Hilfe von Röntgenabsorptionsmessungen und XMCD untersucht. Durch die Vergleiche mit Zn3Dinit1Dicnq und den jeweiligen Verbindungen mit koordinierten Rutheniumionen (Cu3Dinit1Dicnq-1Ru, Zn3Dinit1Dicnq-1Ru) konnte gezeigt werden, dass eine Verschiebung der Elektronendichte des Rutheniumions zu dem zentralen Kupferion des Makrozyklus stattgefunden hat und durch die Koordination eines Rutheniumions in der Peripherie des Tetraazaporphyrins die energetische Lage der Kupferorbitale beeinflusst wird.rnDer Einfluss von vier koordinierten Ruthenium(II)-ionen auf das zentrale Kupferion wurde an Hand des in dieser Arbeit hergestellten Kupfer(II)phenanthralocyanins (Cu4Dicnq) untersucht, das aus vier Dicnq-Liganden und Kupfer(II)-acetat synthetisiert wurde. Auf Grund der schlechten Löslichkeit wurde für die Koordination der Rutheniumionen der Prekursor [Ru(bipy)2Dicnq](PF6)2 hergestellt und daraus der Makrozyklus in einer Templatsynthese mit Kufper(II)-ionen gebildet. Durch diese neue Syntheseroute war es möglich, die Verbindung Cu4Dicnq-4Ru herzustellen und ebenfalls durch Röntgenabsorption und XMCD zu untersuchen und so das Spin- und Bahnmoment zu ermitteln. Ein Teil der Elektronendichte des Rutheniumions in dieser Verbindung wird auf die zusätzlich an das Rutheniumion koordinierten 2,2'-Bipyridine und nicht auf den Makrozyklus, wie in Cu3Dinit1Dicnq-1Ru, geschoben. Trotzdem konnte die Funktionsweise als Modell des Photosystems II durch eine Oxidation durch die Bestrahlung mit einer Quecksilberlampe mit para-Benzochinon beobachtet werden. Dies bestätigte die Funktionsweise des Kupfer(II)phenanthralocyanins mit koordinierten Rutheniumionen, da ein durch Licht induzierter Elektronenübergang auf das para-Benzochinon stattgefunden hat.rn

Protein buffering in model systems and in whole human saliva

The aim of this study was to quantify the buffer attributes (value, power, range and optimum) of two model systems for whole human resting saliva, the purified proteins from whole human resting saliva and single proteins. Two model systems, the first containing amyloglucosidase and lysozyme, and the second containing amyloglucosidase and alpha-amylase, were shown to provide, in combination with hydrogencarbonate and di-hydrogenphosphate, almost identical buffer attributes as whole human resting saliva. It was further demonstrated that changes in the protein concentration as small as 0.1% may change the buffer value of a buffer solution up to 15 times. Additionally, it was shown that there was a protein concentration change in the same range (0.16%) between saliva samples collected at the time periods of 13:00 and others collected at 9:00 am and 17:00. The mode of the protein expression changed between these samples corresponded to the change in basic buffer power and the change of the buffer value at pH 6.7. Finally, SDS Page and Ruthenium II tris (bathophenantroline disulfonate) staining unveiled a constant protein expression in all samples except for one 50 kDa protein band. As the change in the expression pattern of that 50 kDa protein band corresponded to the change in basic buffer power and the buffer value at pH 6.7, it was reasonable to conclude that this 50 kDa protein band may contain the protein(s) belonging to the protein buffer system of human saliva.

Development of an electrochemical maltose biosensor

In this work, electrochemical maltose biosensors based on mutants of the maltose binding protein (MBP) are developed. A ruthenium II complex (Ru II ), which is covalently attached to MBP, serves as an electrochemical reporter of MBP conformational changes. Biosensors were made through direct attachment of Ru II complex modified MBP to gold electrode surfaces. The responses of some individual mutants were evaluated using square wave voltammetry. A maltose-dependent change in Faradic current and capacitance was observed. It is therefore demonstrated that biosensors using generically this family of bacterial periplasmic binding proteins (bPBP) can be made lending themselves to facile biorecognition element preparation and low cost electrochemical transduction.

Redox transitions between oxygen intermediates in cytochrome-c oxidase.

Some intermediates in the reduction of O2 to water by cytochrome-c oxidase have been characterized by optical, Raman, and magnetic circular dichroism spectroscopy. The so-called "peroxy" (P) and "ferryl" (F) forms of the enzyme, which have been considered to be intermediates of the oxygen reaction, can be generated when the oxidized enzyme reacts with H2O2, or when the two-electron reduced ("CO mixed-valence") enzyme reacts with O2. The structures as well as the overall redox states of P and F have recently been controversial. We show here, using tris(2,2'-bipyridyl)ruthenium(II) as a photoinducible reductant, that one-electron reduction of P yields F, and that one-electron reduction of F yields the oxidized enzyme. This confirms that the overall redox states of P and F differ from the oxidized enzyme by two and one electron equivalents, respectively. The structures of the P and F states are discussed.